Literature DB >> 1643643

Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation.

Y Arita1, K R O'Driscoll, I B Weinstein.   

Abstract

To investigate the role of protein kinase C (PKC) in the 12-O-tetradecanoylphorbol-13-acetate (TPA)-dependent growth of human melanocytes, we analyzed the effects of phorbol ester treatment on both PKC expression and growth control in these cells. We found that established cultures of normal melanocytes contain the PKC alpha, PKC beta, and PKC epsilon isoforms. The abilities of various phorbol ester compounds to stimulate DNA synthesis in these cultured melanocytes correlated with their known potencies for activation of PKC and tumor promotion. Dose-response studies revealed that the most effective TPA concentration for stimulation of DNA synthesis and growth of melanocytes (10 ng/ml TPA) also supported a relatively high level of PKC enzyme activity, increased membrane association of the PKC alpha and PKC epsilon isoforms, and led to a high level of phosphorylation of a major PKC substrate, the myristoylated alanine-rich C kinase substrate (MARCKS) protein. Melanocytes incubated for 48 h with TPA at a higher concentration (100 ng/ml TPA) exhibited suboptimal TPA-stimulated DNA synthesis (28% of maximal) and decreased phosphorylation of the MARCKS substrate protein (50% of maximal). Furthermore, treatment of melanocytes with 100 ng/ml TPA for 48 h resulted in a marked decrease in total PKC enzyme activity and the loss of expression of the PKC alpha and PKC epsilon isoforms in both the cytosol and membrane-bound fractions, when examined by immunoblot analysis. These results, taken together, suggest that continuous activation of PKC by TPA, rather than the loss of PKC due to TPA-induced down-regulation, is responsible for the growth-stimulatory effects of phorbol esters on normal human melanocytes. Additionally, the conditioned medium from TPA-treated human melanocytes stimulated DNA synthesis in quiescent melanocytes and human melanoma cells, thus suggesting that activation of the PKC signaling pathway in melanocytes leads to the production of an autocrine growth factor. These findings may be relevant to the autonomous growth of malignant melanomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643643

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Activation of protein kinase C-alpha isoform in murine melanoma cells with high metastatic potential.

Authors:  C A La Porta; R Comolli
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  A Comparison Between Phorbol 12 Myristate 13 Acetate and Phorbol 12, 13 Dibutyrate in Human Melanocyte Culture.

Authors:  Divya Padma; Kumar M R Bhat
Journal:  J Clin Diagn Res       Date:  2016-01-01

3.  Terminal differentiation and senescence in the human melanocyte: repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes.

Authors:  E E Medrano; F Yang; R Boissy; J Farooqui; V Shah; K Matsumoto; J J Nordlund; H Y Park
Journal:  Mol Biol Cell       Date:  1994-04       Impact factor: 4.138

4.  Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.

Authors:  X Chen; Q Wu; L Tan; D Porter; M J Jager; C Emery; B C Bastian
Journal:  Oncogene       Date:  2013-10-21       Impact factor: 9.867

5.  A kinase-independent function of AKT promotes cancer cell survival.

Authors:  Igor Vivanco; Zhi C Chen; Barbara Tanos; Barbara Oldrini; Wan-Ying Hsieh; Nicolas Yannuzzi; Carl Campos; Ingo K Mellinghoff
Journal:  Elife       Date:  2014-12-31       Impact factor: 8.140

6.  BRAFV600E induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB.

Authors:  Andrew S McNeal; Rachel L Belote; Hanlin Zeng; Marcus Urquijo; Kendra Barker; Rodrigo Torres; Meghan Curtin; A Hunter Shain; Robert Hi Andtbacka; Sheri Holmen; David H Lum; Timothy H McCalmont; Matt W VanBrocklin; Douglas Grossman; Maria L Wei; Ursula E Lang; Robert L Judson-Torres
Journal:  Elife       Date:  2021-11-23       Impact factor: 8.140

Review 7.  Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Authors:  Jérémy H Raymond; Zackie Aktary; Lionel Larue; Véronique Delmas
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.